Evidence map›Paper›PMID 42012336›Full record

ArticleeLife2026

PPIscreenML is a method for structure-based screening of protein-protein interactions using AlphaFold.

Victoria Mischley, Johannes Maier, Jesse Chen, John Karanicolas

Abstract read
In one paragraph

Article in eLife, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Assessing scoring metrics for AlphaFold2 and AlphaFold3 protein complex predictions.Protein science : a publication of the Protein Society · 2025
    Article
  3. Article
  4. Recent progress and future challenges in structure-based protein-protein interaction prediction.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Review
  5. bioRxiv : the preprint server for biology · 2025
    Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Victoria MischleyCancer Signaling and Microenvironment Program, Fox Chase Cancer Center, Philadelphia, United States.
Johannes MaierTriana Biomedicines, Lexington, United States.
Jesse ChenTriana Biomedicines, Lexington, United States.
John KaranicolasCancer Signaling and Microenvironment Program, Fox Chase Cancer Center, Philadelphia, United States.ORCID https://orcid.org/0000-0003-0300-726X

Funding

WORD PROCESSING CENTER--COREP30CA006927 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Eric Andrew Ross · 1985 to 2026
$138.8M
Designing selective kinase inhibitors via deep learningR01GM141513 · NIGMS · RESEARCH INST OF FOX CHASE CAN CTR · PI RINK, LORI · 2022 to 2025
$2.4M
Developing computational methods to identify of endogenous substrates of E3 ubiquitin ligases and molecular glue degradersF30EB034594 · NIBIB · DREXEL UNIVERSITY · PI MISCHLEY, VICTORIA · 2023 to 2025
$132k
National Science Foundation MCB130049NCI NIH HHS P30 CA006927NIBIB NIH HHS F30 EB034594NIGMS NIH HHS R01 GM141513NIH HHS F30EB034594NIH HHS P30CA006927NIH HHS R01GM141513
6 · The paper itself

Abstract

Protein-protein interactions underlie nearly all cellular processes. With the advent of protein structure prediction methods such as AlphaFold2 (AF2), models of specific protein pairs can be built extremely accurately in most cases. However, determining the relevance of a given protein pair remains an open question. It is presently unclear how to use best structure-based tools to infer whether a pair of candidate proteins indeed interacts with one another: ideally, one might even use such information to screen among candidate pairings to build up protein interaction networks. Whereas methods for evaluating quality of modeled protein complexes have been co-opted for determining which pairings interact (e.g. pDockQ and iPTM), there have been no rigorously benchmarked methods for this task. Here, we introduce PPIscreenML, a classification model trained to distinguish AF2 models of interacting protein pairs from AF2 models of compelling decoy pairings. We find that PPIscreenML outperforms methods such as pDockQ and iPTM for this task, and further that PPIscreenML exhibits impressive performance when identifying which ligand/receptor pairings engage one another across the structurally conserved tumor necrosis factor superfamily (TNFSF). Analysis of benchmark results using complexes not seen in PPIscreenML development strongly suggests that the model generalizes beyond training data, making it broadly applicable for identifying new protein complexes based on structural models built with AF2.

Indexed as

Computational BiologyProtein Interaction MappingProteinsModels, MolecularProtein BindingProtein ConformationProteinsmolecular biophysicsnoneprotein complexprotein interactionsstructural biologystructure prediction

Identifiers

PMID42012336
PMCPMC13099138

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.